An adult recipient of mental health services in Illinois has the right to refuse medication. A refusal must be honored, except in two circumstances.¹

In the first circumstance, upon a written petition, a circuit court finds by “clear and convincing” evidence that the recipient meets certain statutory criteria.² This first scenario typically occurs in a “nonemergency” setting and is subject to a variety of safeguards (including expert testimony and cross-examination of the same).
In the second circumstance, which is the subject of this article, administration of medication is due to a perceived “emergency”, something that is oftentimes subjective, and therefore, can potentially violate an individual’s rights.³ Unlike the first-described situation, where judicial involvement is mandated (along with a burden of proof), this second circumstance involves administering medications without prior consent from a court. Given this, clarity and consistency in the administration of such medications in an emergency setting is imperative. Illinois law provides a statutory framework for such situations, but concern and confusion continue to dominate the landscape statewide over when psychotropic medications may be administered in an “emergency” despite a recipient’s refusal.

To understand how a valid application of emergency medications works in practice, one should begin with the premise that a refusal of medication is a right.⁴ If services are refused, then “[treatment] shall not be given unless such services are necessary to prevent the recipient from causing serious and imminent physical harm to the recipient or others and no less restrictive alternative is available.”⁵ This “exception of necessity” is commonly referred to as “emergency treatment”. As set forth below, a facility’s deployment of such treatment must follow strict statutory framework and heed its limitations.

Given that the statute contemplates emergency treatment as necessary to prevent “serious and imminent physical harm” to themselves or others, one may initially conclude that such events are momentary and likely only arise during a scenario lasting mere minutes. Accordingly, the application of forced medication should correlate with said limited timeframe. In practice, however, some treatment centers and practitioners may employ a far-too-generous application of the statute’s contemplation of when treatment is necessary to prevent imminent harm and how long such treatment is needed to assuage any immediate concerns.
Any extended administration of such refused medications (or blatant overuse) must square with the Mental Health and Development Disabilities Code (the “Code”), which warns “[p]sychotropic medication or electroconvulsive therapy may be administered under this Section for up to 24 hours only if the circumstances leading up to the need for emergency treatment are set forth in writing in the recipient's record.”⁶ In other words, the rationale for all treatment, as described above, must be clearly documented. Failure to clearly document the treatment given and why the treatment was given can only invite future scrutiny and potential litigation.⁷

The administration of emergency medications can be traumatizing, particularly when this treatment is given involuntarily.⁸ However, at times, such drastic treatment measures must be taken in order to immediately protect the well-being of the patient and those around them as stated in 405 ILCS 5/2- 107(a).⁹ When administering these types of emergency and short-lasting treatments, health care professionals must carefully re-evaluate and document the need for the treatment every 24 hours and remain mindful of a hard “cap” 72-hour limitation window of time in which such medications may be consistently administered (even if every 24 hours the need for treatment is re-justified).¹⁰

These articulated limitations sometimes give rise to confusion among practitioners. The most common source of disagreement or uncertainty stems from 405 ILCS 5/2-107(d) which states in part that “[n]either psychotropic medication nor electroconvulsive therapy may be administered under this section for a period in excess of 72 hours…unless a petition is filed…and treatment continues to be deemed necessary, by a health care provider.”¹¹

Some psychiatrists and staff assume this to mean that an individual may be medicated for 72 hours by “emergency” without much additional thought or documentation. However, and to reiterate, even if such a period of medication is deemed “necessary”, the facts and supporting record for such a prolonged treatment without court oversight must still be redetermined (and recorded) at least every 24 hours during that 72-hour window and must be “based upon a personal examination of the recipient by a physician or a nurse under the supervision of a physician”.¹² This daily redetermination serves as a stopgap to ensure treatment teams are not initially adjudicating an emergency and then going on to administer prolonged, forced medications without any documented reassessment of the facts constituting the emergency.¹³ Given the drastic implications of forced medications, this 24-hour written reassessment is a small “ask” of the facility and treaters should be mindful of its requirements.

By contrast, consider the provider’s options if the treatment team concurrently filed a petition pursuant to 405 ILCS 5/2–107.1(a–5)(4). If a petition was pending, and the necessary factors were present to constitute an emergency, then the 72-hour cap would not apply. What’s more, consider an unsettling application of the statute if “emergency” medications were administered consistently from Tuesday all the way up through a Sunday without a break. If an advocate for the patient contends that such emergency medication was an abuse, what is the response by the treatment team if the Thursday of that week also happened to be on a holiday?¹⁴

An additional (and significant) limitation that some staff altogether disregard (or aren’t aware of) is that long-acting psychotropic medications (commonly referred to long acting injectable antipsychotics or LAIs) should never be administered as “emergency” medication.¹⁵ Unlike the administration of emergency medications, the use of an LAI such as haloperidol decanoate, which is given via intramuscular injection, has effects which can last up to 30 days. Such treatment, by definition, lasts much longer than medications typically used in a psychiatric emergency (such as short-acting haloperidol or Thorazine or Zyprexa). LAIs are prohibited from being administered involuntarily without a petition being filed (and granted) which specifically states that a patient needs to receive the long-acting antipsychotic medication. The policy and logic behind this distinction should be apparent but some treatment teams, unfortunately, must be reminded why such a potent and long-acting medication must not be given without a full hearing on the various factors set forth by Illinois law. Absent a court order, paternalism must yield to autonomy.

It is understandable that some treatment teams may feel frustrated or impatient with the law’s limitations regarding forced emergency medication. An alternate angle to consider is that emergencies are fact-based events. The facts that motivate one psychiatrist to invoke medication to “prevent serious and imminent harm” may not be the same for another psychiatrist. Further, such decisions are not judicially reviewed or scrutinized by authorities prior to treatment. Because of this, limitations are important. Similarly, some experts even contend that recognizing a patient’s right to refuse (and making that refusal easier and respected) can actually lead to more and more patients consenting to medication.¹⁶

Simply stated, emergency medications are for emergencies. Time and again, there is an ever-growing suspicion that some facilities overutilize the emergency treatment statute in lieu of filing a court proceeding that would require time, attention and scrutiny. This is fundamentally improper and emergency medications are not a substitute for substantive, dedicated treatment. Hospital teams should routinely be asking themselves whether their aim is to “get someone out” of a facility by quick-acting medications or “keep someone out” by engaging in collaborative care plans and long-view discharge planning. Such introspection may not only save the hospital time, money and repeated admissions, but ultimately it could accomplish what motivated care from the very beginning: a person with better health, insight and comprehensive care.

Sarah Berkowitz is a B.A. Candidate (2021), at the University of Iowa. During 2018, she performed work on behalf of the Illinois Guardianship and Advocacy Commission. In addition to this article, she participated in a variety of projects at the Commission on behalf of a diverse population, and the attorneys at the Commission are grateful to her dedication.

Matthew Davison is an attorney with Legal Advocacy Service, a division of the Illinois Guardianship and Advocacy Commission. He represents respondents whom are subject to petitions for involuntary administration of psychotropic medication and petitions for involuntary commitment. He may be contacted by email at: Matthew.Davison@illinois.gov and by phone: 708-338-7747.